Kazuki Takasaki

Kazuki Takasaki

Auto-generated profile, based on publicly available information

Kazuki Takasaki

Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama, 359-8513, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2022 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
KTKazuki Takasaki
Kazuki Takasaki
HHHirofumi Henmi
Hirofumi Henmi
UIUtako Ikeda
Utako Ikeda
TEToshiaki Endo
Toshiaki Endo
AAAtsushi Azumaguchi
Atsushi Azumaguchi
KNKazunori Nagasaka
Kazunori Nagasaka

9 May 2019 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
KTKazuki Takasaki
Kazuki Takasaki
MMMorikazu Miyamoto
Morikazu Miyamoto
MTMasashi Takano
Masashi Takano
HSHiroaki Soyama
Hiroaki Soyama
TATadashi Aoyama
Tadashi Aoyama
KFKenichi Furuya
Kenichi Furuya


2 March 2018 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
KTKazuki Takasaki
Kazuki Takasaki
MMMorikazu Miyamoto
Morikazu Miyamoto
MTMasashi Takano
Masashi Takano
HSHiroaki Soyama
Hiroaki Soyama
TATadashi Aoyama
Tadashi Aoyama
KFKenichi Furuya
Kenichi Furuya

Verified
Journal Article
Open access
PDF file
KHKei Hashimoto
Kei Hashimoto
YMYuko Miyagawa
Yuko Miyagawa
SWSaya Watanabe
Saya Watanabe
KTKazuki Takasaki
Kazuki Takasaki
MNMiki Nishizawa
Miki Nishizawa
Kazunori NagasakaKazunori Nagasaka
Kazunori Nagasaka
Placenta accreta is a high-risk condition causing obstetric crisis and hemorrhage; however, its pathogenesis remains unknown. We aimed to identify the factors contributing to trophoblast invasiveness and angiogenic potential, which in turn drive the pathogenesis of placenta accreta. We focused on the transforming growth factor (TGF)-β1-Smad pathway and investigated the intrinsic relationship between the time- and dose-dependent inhibition of the ubiquitinating enzyme UCHL5 using bAP15, a deubiquitinase inhibitor, after TGF-β1 stimulation and the invasive and angiogenic potential of two cell lines, gestational choriocarcinoma cell line JEG-3 and trophoblast cell line HTR-8/SVneo. UCHL5 inhibition negatively regulated TGF-β1-induced Smad2 activation, decreasing extravillous trophoblast invasiveness. Smad1/5/9 and extracellular signal-regulated kinase (ERK) were simultaneously activated, and vascular endothelial growth factor was secreted into the trophoblast medium. However, extravillous trophoblast culture supernatant severely impaired the vasculogenic potential of human umbilical vein endothelial cells. These results suggest that the downstream ERK pathway and Smad1/5/9 potentially regulate the TGF-β1-Smad pathway in extravillous trophoblasts, whereas Smad2 contributes to their invasiveness. The abnormal invasive and angiogenic capacities of extravillous cells, likely driven by the interaction between TGF-β1-Smad and ERK pathways, underlie the pathogenesis of placenta accreta.